Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
《临床淋巴瘤、骨髓瘤和白血病》是一份同行评审的月刊，发表描述淋巴瘤、骨髓瘤和白血病临床和转化研究各个方面的原创文章。临床淋巴瘤，骨髓瘤和白血病是致力于检测，诊断，预防和治疗淋巴瘤，骨髓瘤，白血病和相关疾病，包括巨球蛋白血症，淀粉样变性，浆细胞恶液质的文章。重点是淋巴瘤、骨髓瘤和白血病相关领域的最新科学进展。感兴趣的具体领域包括临床研究和机械方法;药物敏感性和耐药性;基因和反义治疗;病理学、标志物和预后指标;化学预防策略;综合疗法;以及各种方法的综合。
Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS‐mutant Acute Myeloid Leukemia
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2018.12.009
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.04.018
Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2018.08.016
Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.08.008
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2018.09.002
Total Skin Electron Beam Therapy for Mycosis Fungoides Revisited With Adjuvant Systemic Therapy
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2018.11.015
Recent Advances in CAR-T Cell Therapy for Non-Hodgkin Lymphoma.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.09.598
Prophylactic Use of Entecavir for Lymphoma Patients With Past Hepatitis B Virus Infection: A Randomized Controlled Trial
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2018.11.008
Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2018.10.005
Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.04.014
Clinicopathological Profile of Myelomatous Pleural Effusion: Single‐center Real‐world Experience and Review of Literature
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2018.12.003
Fibril-directed Therapies in Systemic Light Chain AL Amyloidosis.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.03.029
Management of Polycythemia Vera: A Survey of Canadian Physician Practice Patterns.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2018.07.297
Prognostic Significance of Serum Copper in Patients With Cutaneous T‐cell Lymphoma
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2018.12.020
Effects of Obesity on Overall Survival of Adults With Acute Myeloid Leukemia.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.11.001
Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.05.004
Rosai-Dorfman Disease: The MD Anderson Cancer Center Experience.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.06.013
Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2018.11.010
Therapeutic Potential of Checkpoint Inhibitors in Refractory Plasmablastic Lymphoma.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.06.008
Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.05.008
Prevalence and Clinical Outcome of Philadelphia-Like Acute Lymphoblastic Leukemia: Systematic Review and Meta-analysis.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.08.003
Immune-related Adverse Events Associated With Checkpoint Inhibition in the Setting of CAR T Cell Therapy: A Case Series.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.12.014
Prognostic Impact of ABO Blood Group on Survival in Patients With Malignant Lymphoma.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.09.607
Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.09.615
Rapid Reduction of Peripheral Blasts in Older Patients with Refractory Acute Myeloid Leukemia (AML) Using Re-Induction with Single Agent Anti-CD45 Targeted Iodine (131I) Apamistamab [Iomab-B] Radioimmunotherapy in the Phase III SIERRA Trial
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2019.07.117
Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.08.007
Multicenter Phase 2 Study of Reduced‐Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B‐Cell Lymphoma
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2018.11.003
Temozolomide as a Single Agent Maintenance Therapy in Elderly Patients With Primary CNS Lymphoma.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.05.012
Nutrition-Related Outcomes for Autologous Stem Cell Transplantation Patients.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.04.002
Chronic Neutrophilic Leukemia: Current and Future Perspectives
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2018.11.012
Pathologic Findings in Bronchopulmonary Leukemic Infiltrates in Patients With Chronic Lymphocytic Leukemia
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2018.11.005
Optimal Time Points for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis on the Basis of European LeukemiaNet Recommendations in Chronic Myeloid Leukemia.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.02.003
Impact of the Conditioning Regimen Dose Intensity Before Autologous Stem Cell Transplantation on the Pulmonary Function Test Abnormalities in Patients With Lymphoma and Multiple Myeloma: Single Center Experience.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.10.015
RETRACTED: Drug-Induced Thrombocytopenia.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.07.336
Outcome of Imatinib Treatment in Yemeni Patients With Chronic Myeloid Leukemia and the Influence of Nonadherence to Treatment and Duration of Previous Hydroxyurea Therapy.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.11.015
Decitabine Versus Intensive Chemotherapy for Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.02.002
Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value-A Multicenter Study From South India.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.09.606
High-dose Therapy and Autologous Hematopoietic Cell Transplantation as Consolidation Treatment for Primary Effusion Lymphoma.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.03.021
Priorities for Rural Lymphoma Survivors: A Qualitative Study.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.09.599
Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.11.012
POEMS Syndrome: Indian Experience From a Tertiary-Care Institute.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.05.018
Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents?
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.05.020
Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.03.023
Effect of Exposure to Agent Orange on the Risk of Monoclonal Gammopathy and Subsequent Transformation to Multiple Myeloma: A Single-Center Experience From the Veterans Affairs Hospital, Detroit.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.11.014
Feasibility of Qualitative Testing of BCR‐ABL and JAK2 V617F in Suspected Myeloproliperative Neoplasm (MPN) Using RT‐PCR Reversed Dot Blot Hybridization (RT‐PCR RDB)
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2019.01.005
Hematological Malignancies in the Polish Population: What are the Predictors of Outcome in Patients Admitted to Intensive Care Unit?
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2019.07.093
Acute Myeloid Leukemia in Mexico: The Specific Challenges of a Developing Country. Results From a Multicenter National Registry.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/j.clml.2019.12.015
Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma
来源期刊：Clinical Lymphoma, Myeloma & LeukemiaDOI：10.1016/j.clml.2018.11.020
Familial Cancer: How to Successfully Recruit Families for Germline Mutations Studies? Multiple Myeloma as an Example.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.06.012
Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell Lymphoma.
来源期刊：Clinical lymphoma, myeloma & leukemiaDOI：10.1016/J.CLML.2019.04.010
